Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.
about
Dosing of antibacterial agents in obese adults: does one size fit all?The Daniel K. Inouye College of Pharmacy Scripts: Obesity: The Drug Dose Debate.Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infectionsPreventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens.The standard one gram dose of vancomycin is not adequate prophylaxis for MRSAEmpiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.Vancomycin dosing in healthy-weight, overweight, and obese pediatric patients.Alteration of hepatic but not renal transporter expression in diet-induced obese miceBiopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity.The association of elevated trough serum vancomycin concentrations with obesity.Prophylactic use of vancomycin in adult cardiology and cardiac surgery.Bayesian Estimation of Vancomycin Pharmacokinetics in Obese Children: Matched Case-Control Study.What is the best size descriptor to use for pharmacokinetic studies in the obese?Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology.An Evaluation of Systemic Vancomycin Dosing in Obese PatientsShould monitoring of vancomycin be delayed? A case of likely nephrotoxicity occasioned by morbid obesity and minimal monitoring.Evaluation of a New Vancomycin Dosing Protocol in Morbidly Obese PatientsMulticenter evaluation of vancomycin dosing: emphasis on obesity.The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.Vancomycin dosing in patients on intermittent hemodialysis.Implications of obesity for drug therapy: limitations and challenges.Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years.Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application.Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.Comprehensive Guidance for Antibiotic Dosing in Obese Adults.Population pharmacokinetic parameters of vancomycin in critically ill patients.Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type.Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.Surgical site infections following bariatric surgery in community hospitals: a weighty concern?Vancomycin Dosing in Obese Patients: Special Considerations and Novel Dosing Strategies.
P2860
Q30362353-6AD58327-189F-4624-9C5D-CD4895E6F11BQ33763123-499CC713-E871-4CDC-B659-183E6EE96F3AQ33881584-FE45F0CC-9F1C-4A34-AF1D-B2507B8C4E9DQ33995500-CF3F9ADB-24E6-4E3A-94CC-AD465F9D0CECQ34024012-1CB265FC-4FFF-41BC-8EF0-F7586DA888D2Q34249501-34B6CA08-D51D-4953-A42E-3BAC4A025AD1Q34297295-D5859A99-F438-48B2-A1D0-2A31A95D019DQ35002476-F953083A-F452-4DA5-91D1-7E39671D5E13Q35055669-52326D81-EBDE-4311-965C-134DB43CB09EQ35744137-B2D4C6CC-418D-4BA5-837E-685308ACD221Q35750208-25692598-B2F3-46A6-9AF9-53729F4DC1FDQ35762761-3EE9D0EF-6213-4FA4-A763-F744A7F4A3B4Q35826324-4DF898D1-0CD8-4C23-AB30-8E652179CB0EQ36111191-EC854F4F-E72B-47D2-AA32-B75737D97E48Q36405861-0B6CD30C-51C9-4786-8E1D-180529A39C7CQ36468173-2A8D46DB-ACF9-450E-BB5A-B83B068FC744Q36572423-80DA51DE-50E5-4A94-B692-44E1221DA361Q36961341-E91C5917-4BC9-438F-B5DA-D0682DABD6ACQ37347361-B541F702-CE73-4FFF-9B21-3FB3C0836FC7Q37845424-0DE403F5-CDB8-4B19-8B7A-BA20C36FA175Q37883897-608171D5-451D-4478-AD69-31C8485EC5D3Q37989803-506BDCE8-7677-4912-9917-DBF49B7EBE40Q38137251-F9333A5E-69AE-4E82-ADF5-F77A666D129FQ38247400-158E71EB-E2F5-4D85-A361-5D6D1D403EC7Q38258649-7CB9D7AB-F89E-4F98-B4DD-C5D36456D31DQ38882052-B8D3F88D-FFD3-4716-AEC5-E64744509A6BQ38910495-409F7160-7CF8-45F1-B8FC-3CFD09B850AFQ39017701-5C5F59DE-2F71-4454-A914-EF78AF282EECQ39375881-99AED7F2-4770-4530-8E88-679FF8BC06D9Q40067964-00F682CA-A54C-4FE0-A613-350514E0EFC5Q40290397-2BDF9BF3-BA54-4986-8096-CA51FAD9F84CQ43984406-4812F4BB-E4CF-4DD8-B732-A73A53C67199Q45937025-F0C5219C-D075-4C1C-A1DE-8C14730AF114Q46027436-0A999491-0413-4B49-879E-387C2DD3148CQ46112123-F2A52808-EE65-447F-A679-1D6AC846BE1DQ47275031-FF461106-1A24-41A3-8CD8-9DFD411F6DF1
P2860
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Effect of obesity on vancomyci ...... ayesian forecasting technique.
@ast
Effect of obesity on vancomyci ...... ayesian forecasting technique.
@en
type
label
Effect of obesity on vancomyci ...... ayesian forecasting technique.
@ast
Effect of obesity on vancomyci ...... ayesian forecasting technique.
@en
prefLabel
Effect of obesity on vancomyci ...... ayesian forecasting technique.
@ast
Effect of obesity on vancomyci ...... ayesian forecasting technique.
@en
P2093
P2860
P356
P1476
Effect of obesity on vancomyci ...... ayesian forecasting technique.
@en
P2093
Gilliland SS
Rodvold KA
Rotschafer JC
Vance-Bryan K
P2860
P304
P356
10.1128/AAC.37.3.436
P407
P577
1993-03-01T00:00:00Z